ArticleExperimental and therapeutic medicine2022

Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study.

Vasiliki Epameinondas Georgakopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.